Pediatric Terrorism and Disaster Preparedness: A ... - PHE Home
Pediatric Terrorism and Disaster Preparedness: A ... - PHE Home
Pediatric Terrorism and Disaster Preparedness: A ... - PHE Home
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Appropriate Triage.............................................................................................................40<br />
Incident Management.....................................................................................................................41<br />
Staging ...............................................................................................................................42<br />
Triage Group......................................................................................................................42<br />
Treatment/Decontamination ..............................................................................................42<br />
Transportation....................................................................................................................43<br />
Bibliography ..................................................................................................................................43<br />
Chapter 4. Biological <strong>Terrorism</strong> ..................................................................................47<br />
Background....................................................................................................................................47<br />
History of Bioterrorism......................................................................................................47<br />
Epidemiology of a Terrorist Attack ...................................................................................49<br />
Agents Categorized by System Predominantly Affected...............................................................50<br />
Respiratory System ............................................................................................................50<br />
Nervous System .................................................................................................................51<br />
Gastrointestinal System .....................................................................................................52<br />
Dermatologic Manifestations.............................................................................................52<br />
Notifying Authorities.....................................................................................................................54<br />
Health Department.............................................................................................................55<br />
Hospital..............................................................................................................................55<br />
Law Enforcement...............................................................................................................56<br />
Laboratory Support <strong>and</strong> Submission of Specimens...........................................................56<br />
Laboratory Response Network ..........................................................................................56<br />
Limiting Spread .............................................................................................................................56<br />
St<strong>and</strong>ard Precautions..........................................................................................................56<br />
Transmission Precautions ..................................................................................................57<br />
Equipment <strong>and</strong> Supplies ................................................................................................................58<br />
<strong>Pediatric</strong> Practices..........................................................................................................................59<br />
Managing Patients: Treatment <strong>and</strong> Prevention..............................................................................60<br />
Smallpox Vaccine ..............................................................................................................60<br />
Anthrax Vaccine ................................................................................................................61<br />
Strategic National Stockpile ..........................................................................................................61<br />
Surge Capacity...............................................................................................................................62<br />
Medications........................................................................................................................62<br />
Isolation..............................................................................................................................62<br />
Vaccination ........................................................................................................................63<br />
Information for Families................................................................................................................63<br />
Category A Agents.........................................................................................................................63<br />
Anthrax ..............................................................................................................................63<br />
Botulinum Toxin................................................................................................................66<br />
Plague.................................................................................................................................69<br />
Smallpox ............................................................................................................................71<br />
Tularemia ...........................................................................................................................74<br />
Viral Hemorrhagic Fevers..................................................................................................76<br />
Category B <strong>and</strong> C Agents ..............................................................................................................77<br />
Ricin...................................................................................................................................77<br />
iv